Global Biological Evaluation Services Market Growth (Status and Outlook) 2025-2031

According to this study, the global Biological Evaluation Services market size will reach US$ 8728 million by 2031.

Biological evaluation services are a type of comprehensive research service that conducts toxicological, safety, effectiveness and mechanism studies on drugs, medical devices, biomaterials and other products through in vitro, in vivo or computational simulation. This service covers acute/chronic toxicity, immunotoxicology, genotoxicity, pharmacokinetics, biocompatibility, cell function evaluation and other contents. It is widely used in new drug development, medical device registration, biomaterial certification and other fields, and is an indispensable and important support means in the preclinical research and development stage. With the tightening of regulations and the strengthening of the trend of R&D outsourcing, the biological evaluation service market is developing rapidly and has become an important part of the CRO/CMO system.

United States market for Biological Evaluation Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Biological Evaluation Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Biological Evaluation Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Biological Evaluation Services players cover Charles River Laboratories, Labcorp, Namsa, SGS SA, TVU SUD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Biological Evaluation Services Industry Forecast” looks at past sales and reviews total world Biological Evaluation Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Biological Evaluation Services sales for 2025 through 2031. With Biological Evaluation Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biological Evaluation Services industry.

This Insight Report provides a comprehensive analysis of the global Biological Evaluation Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biological Evaluation Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biological Evaluation Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biological Evaluation Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biological Evaluation Services.

This report presents a comprehensive overview, market shares, and growth opportunities of Biological Evaluation Services market by product type, application, key players and key regions and countries.

Segmentation by Type:
Toxicology Evaluation
Safety Pharmacology
Immunology Evaluation
Others

Segmentation by Application:
Drugs
Medical Devices
Diagnostic Reagents
Biomaterials
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River Laboratories
Labcorp
Namsa
SGS SA
TVU SUD
SenzaGen
LFH Regulatory
Med Institute
SCC Medical Devices
Measurlabs
Sushvin
GBA Key2Compliance
Qserve
Thinqbetter
Groenakker
JordiLabs, LLC
Biotox Laboratories
Gnovo
Yimeida Meoical Device Consulting
Prima Drug Research Center
Mid Link
WuXi AppTec Medical Device Testing Center

Please note: The report will take approximately 2 business days to prepare and deliver. Show more